## Classification of Iodinated Contrast Media ### Osmolality-Based Classification | Parameter | HOCM | LOCM | IOCM | |-----------|------|------|------| | Osmolality (mOsm/kg) | >1400 | 600–900 | ~290 | | Ionic/Non-ionic | Ionic | Non-ionic | Non-ionic | | Nephropathy risk | High | Moderate–low | Low | | Thrombophlebitis risk | High | Low | Low | | Cost | Low | Moderate | High | | Clinical use | Obsolete | Standard | Preferred in high-risk | **Key Point:** While IOCM agents (iopamidol, iodixanol) have osmolality matching plasma (~290 mOsm/kg), they do **NOT** completely eliminate contrast-induced nephropathy (CIN) risk. CIN is multifactorial, involving direct tubular toxicity, renal vasoconstriction, and oxidative stress — osmolality reduction alone does not prevent all mechanisms. **High-Yield:** LOCM are the standard choice for most patients; IOCM are reserved for high-risk groups (severe renal impairment, diabetes, elderly, dehydration) but do not guarantee zero risk. **Clinical Pearl:** The osmolality advantage of IOCM over LOCM is modest in clinical practice; hydration and limiting volume remain the cornerstone of CIN prevention. ### Why Other Options Are Correct - **Option 0 (HOCM):** Correct. HOCM (e.g., diatrizoate) are ionic monomeric agents with high osmolality, now rarely used due to high incidence of adverse effects. - **Option 1 (LOCM):** Correct. Non-ionic monomeric agents (iopamidol, iohexol) are standard for most indications, especially in renal impairment. - **Option 3 (Non-ionic vs ionic):** Correct. Non-ionic agents do not dissociate and cause less osmotic stress and chemotoxicity than ionic agents.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.